Citius Oncology Inc（CTOR）价格预测CTORCitius Oncology Inc

Alphio's CTOR stock price prediction model matches the current Citius Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.51 (+0.89%). The 1-week path is $0.51 (+1.86%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Citius Oncology Inc appears to be a good buy right now due to its recent sales growth, with LYMPHIR sales increasing by 120% in Q4 2026, and the stock's current price of $0.59 being significantly below its 52-week high of $1.83, suggesting potential for recovery. However, the company reported a net loss of $26.61 million in Q2 2026, which poses a risk to its financial stability.

Citius Oncology Inc (CTOR) last closed at $0.5025, gaining +0.48%. These facts feed the 1-day and 1-week CTOR price prediction above.